Search Results for "Lucinactant Phase 2"
Original Source: Phase III Randomized Study of Lucinactant in Full Term Newborn Infants With Meconium Aspiration Syndrome
OBJECTIVES: Evaluate the safety and efficacy of lucinactant administered by bronchoalveolar lavage (BAL) in the treatment of meconium aspiration syndrome (MAS) in newborn infants.
Matching Channels
Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will norma...
Matching News
Lucinactant approved for premie RDS
FDA approves Lucinactant and Peginesatide
Surfaxin lucinactant regulatory update
Plagued, again: Discovery Labs sinks on Surfaxin manufacturing stumbles
After struggling to gain the US FDA's approval to market its respiratory distress syndrome Surfaxin (lucinactant) – finally winning that nod in March – specialty biotech Discovery Labora...
US biotech firm Discovery Laboratories (Nasdaq: DSCO) says that the Food and Drug Administration has requested clarification and provided recommendations regarding the recently-updated product specifi...
Phase IV Patients are a Virtue
Finding patients in a very specific disease state is difficult enough, but in the shadow of Phase III, it’s nearly impossible. In fact, next to Phase IV, Phase III patient enrollment looks easy. ...
Discovery Labs Announces Newly-Released SURFAXIN® (lucinactant) Publications
WARRINGTON, Pa., March 29, 2013 /PRNewswire/ -- Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care,...
2013 Will Be A Telling Year For Discovery Laboratories
By Brian L. Wilson:The specialty biotechnology company Discovery Laboratories (DSCO) seems to be on the mend following the market's disappointment over an Oct. 24 press release that announced a delay...
Anthera 'shoves' for Phase III in SLE after Phase IIb fails
Announcing that the Phase IIb trial of its systemic lupus erythematosus (SLE) treatment, blisibimod (previously A-623) had failed to meet its primary endpoint, Anthera said it would continue with a "m...
Matching PubMed Articles
Lucinactant approved for respiratory distress syndrome.
Improved sinusoidal phase plate to extend depth of field in incoherent hybrid imaging systems.
An improved sinusoidal phase plate is proposed by adding a new parameter to the conventional sinusoidal phase plate. A series of performance comparisons are made among various phase plates, including...
Uncertainty-managed phase-shifting digital holography.
Phase-shifting digital holography is a digital measurement technology of a complex optical field profile that uses focal plane array detectors without the loss of bandwidth. It has been known that the...
Phase Transformation and Crystal Structure of La(2)Ni(7)H(x) Studied by in situ X-ray Diffraction.
The phase transformation of La(2)Ni(7) during hydrogenation was investigated by in situ X-ray diffraction. We found two hydride phases, La(2)Ni(7)H(7.1) (phase I) and La(2)Ni(7)H(10.8) (phase II), dur...
Quantitative phase measurements in imaging, microscopy, and nanooptics provide information not carried in amplitude measurements alone. In this issue of ACS Nano, Honigstein et al. present a new metho...
